Terms: = Cervical cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
40 results:
1. Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication.
Fujii S; Hasegawa K; Maehara T; Kurppa KJ; Heikinheimo K; Warner KA; Maruyama S; Tajiri Y; Nör JE; Tanuma JI; Kawano S; Kiyoshima T
Pathol Res Pract; 2024 Feb; 254():155148. PubMed ID: 38277753
[TBL] [Abstract] [Full Text] [Related]
2. Sigmoid colonic metastasis from a squamous cell carcinoma of the cervix: A rare case report with literature review.
Li M; Zheng W
Medicine (Baltimore); 2024 Jan; 103(3):e37001. PubMed ID: 38241535
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X
Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687
[TBL] [Abstract] [Full Text] [Related]
4. Dihydromyricetin Inhibited Migration and Invasion by Reducing S100A4 Expression through erk1/2/β-Catenin Pathway in Human cervical cancer Cell Lines.
Hsin MC; Hsiao YH; Chen PN; Lin CW; Wang PH; Yang SF; Lee CY
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499426
[TBL] [Abstract] [Full Text] [Related]
5. Human Papillomavirus Modulates Matrix Metalloproteinases During Carcinogenesis: Clinical Significance and Role of Viral Oncoproteins.
Mendonça F; Teles AM; Nascimento MDDSB; Santos APAD; Lopes FF; Paiva A; Brito HO; DA Costa RG
In Vivo; 2022; 36(6):2531-2541. PubMed ID: 36309355
[TBL] [Abstract] [Full Text] [Related]
6. CLCA2 overexpression suppresses epithelial-to-mesenchymal transition in cervical cancer cells through inactivation of erk/JNK/p38-MAPK signaling pathways.
Xin W; Zhang J; Zhang H; Ma X; Zhang Y; Li Y; Wang F
BMC Mol Cell Biol; 2022 Oct; 23(1):44. PubMed ID: 36280802
[TBL] [Abstract] [Full Text] [Related]
7. EFEMP2 increases the invasion ability of cervical cancer cells by promoting EMT via the Raf/MEK/erk signaling pathway.
Li N; Ji GX; Yang ZY
Neoplasma; 2022 Sep; 69(5):1185-1197. PubMed ID: 36004647
[TBL] [Abstract] [Full Text] [Related]
8. Loss of PFKFB4 induces cell cycle arrest and glucose metabolism inhibition by inactivating MEK/erk/c-Myc pathway in cervical cancer cells.
Wu Y; Zhang L; Bao Y; Wan B; Shu D; Luo T; He Z
J Obstet Gynaecol; 2022 Aug; 42(6):2399-2405. PubMed ID: 35659173
[TBL] [Abstract] [Full Text] [Related]
9. Invasive stratified mucin-producing carcinoma (ISMC) of uterine cervix: description of pathological findings and prognosis factors in a series of 15 Chinese patients.
Lin T; Wang W; Xu L; He Y
Arch Gynecol Obstet; 2022 Nov; 306(5):1703-1709. PubMed ID: 35394200
[TBL] [Abstract] [Full Text] [Related]
10. Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer.
Zhang Y; Li N; Yuan G; Yao H; Zhang D; Li N; Zhang G; Sun Y; Wang W; Zeng J; Xu N; Liu M; Wu L
BMC Med; 2022 Feb; 20(1):55. PubMed ID: 35130902
[TBL] [Abstract] [Full Text] [Related]
11. Dysfunction of miR-802 in tumors.
Gao T; Zou M; Shen T; Duan S
J Clin Lab Anal; 2021 Nov; 35(11):e23989. PubMed ID: 34558723
[TBL] [Abstract] [Full Text] [Related]
12. Knockdown of RNF6 inhibits HeLa cervical cancer cell growth via suppression of MAPK/erk signaling.
Zhu K; Bai H; Mu M; Xue Y; Duan Z
FEBS Open Bio; 2021 Jul; 11(7):2041-2049. PubMed ID: 34081837
[TBL] [Abstract] [Full Text] [Related]
13. CircFAT1 facilitates cervical cancer malignant progression by regulating erk1/2 and p38 MAPK pathway through miR-409-3p/CDK8 axis.
Zhou B; Li T; Xie R; Zhou J; Liu J; Luo Y; Zhang X
Drug Dev Res; 2021 Dec; 82(8):1131-1143. PubMed ID: 33818788
[TBL] [Abstract] [Full Text] [Related]
14. Effects of 6,8-Diprenylgenistein on VEGF-A-Induced Lymphangiogenesis and Lymph Node Metastasis in an Oral cancer Sentinel Lymph Node Animal Model.
Bae MG; Hwang-Bo J; Lee DY; Lee YH; Chung IS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466636
[TBL] [Abstract] [Full Text] [Related]
15. Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
Wang A; Liu L; Yuan M; Han S; You X; Zhang H; Lei F; Zhang Y
Oncol Rep; 2020 Dec; 44(6):2656-2668. PubMed ID: 33125133
[TBL] [Abstract] [Full Text] [Related]
16. A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix.
Li H; Jing X; Yu J; Liu J; Zhang T; Chen S; Zhang X
Diagn Pathol; 2020 Aug; 15(1):104. PubMed ID: 32843061
[TBL] [Abstract] [Full Text] [Related]
17. RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1.
Wu H; Song S; Yan A; Guo X; Chang L; Xu L; Hu L; Kuang M; Liu B; He D; Zhao R; Wang L; Wu X; Gu J; Ruan Y
Cancer Lett; 2020 Jan; 469():287-300. PubMed ID: 31705928
[TBL] [Abstract] [Full Text] [Related]
18. Low expression of TUG1 promotes cisplatin sensitivity in cervical cancer by activating the MAPK pathway.
Wei X; Zhou Y; Qiu J; Wang X; Xia Y; Sui L
J BUON; 2019; 24(3):1020-1026. PubMed ID: 31424656
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix.
Zhu R; Wu H; Chen B; Pang J; Huo Z
Diagn Pathol; 2019 Jun; 14(1):64. PubMed ID: 31228945
[TBL] [Abstract] [Full Text] [Related]
20. TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling.
Che Y; Li Y; Zheng F; Zou K; Li Z; Chen M; Hu S; Tian C; Yu W; Guo W; Luo M; Deng W; Zou L
Cancer Lett; 2019 Jun; 452():1-13. PubMed ID: 30905820
[TBL] [Abstract] [Full Text] [Related]
[Next]